Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Compare which total market fund to hold in retirement in 2024 and how to balance it with other assets. Focus on cost, tax efficiency, and diversification.
28,509 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Cava posted a record year, topping rivals with 2025 revenue of $1.169 billion and 72 new restaurants. The chain signa...
Costco emerges as a steadier bet than meme-driven plays, backed by membership cash flow and a durable dividend path. ...
Rocket Lab’s Victus Haze mission signals a broader shift in the space industry—from launching payloads to delivering ...
Four years after their fight, questions about how money flows in celebrity deals continue to surface. This guide unpa...
CrossCountry Mortgage plans a pro rata quarterly dividend for Two Harbors shareholders in the deal closing quarter, a...
A major insider purchase by BORR's Executive Director has investors buzzing. This article breaks down what the move c...
A fintech just reported a blowout quarter, yet the stock still looks cheap to patient investors. This analysis breaks...
Cisco’s latest quarterly results show a robust demand for AI infrastructure. The company boosts its AI targets and or...
SoFi stock has dipped back toward the $18 area, prompting questions about a long-awaited recovery. This guide breaks ...
Kickstarter’s stands 4-day workweek, a bold move for a remote-first company. The CEO says it balances life with high ...
Two of Washington’s most watched political figures disclosed stakes in Vistra, a mid-size energy player poised as AI ...